WeChat Mini Program
Old Version Features

Immune Checkpoint Inhibitors for Patients with Advanced Lung Cancer and Oncogenic Driver Alterations: Results from the IMMUNOTARGET Registry

J. Mazieres,A. Drilon,A. Lusque,L. Mhanna,A. B. Cortot,L. Mezquita,A. A. Thai,C. Mascaux,S. Couraud,R. Veillon,M. Van Den Heuvel,J. Neal,N. Peled,M. Fruh, T. L. Ng,V Gounant,S. Popat,J. Diebold,J. Sabari,V. W. Zhu,S. I. Rothschild,P. Bironzo,A. Martinez-Marti,A. Curioni-Fontecedro,R. Rosell, M. Lattuca-Truc,M. Wiesweg,B. Besse,B. Solomon,F. Barlesi, R. D. Schouten,H. Wakelee,D. R. Camidge,G. Zalcman,S. Novello,S. I. Ou,J. Milia,O. Gautschi

Annals of Oncology（2019）

Cited 1086|Views38
Key words
immunotherapy,lung cancer,oncogenic addiction
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined